Literature DB >> 27591183

Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.

Jason Martin1, Ethan A Halm2, Jasmin A Tiro3, Zahra Merchant4, Bijal A Balasubramanian5, Katharine McCallister6, Joanne M Sanders6, Chul Ahn3, Wendy Pechero Bishop3, Amit G Singal7.   

Abstract

BACKGROUND: Effective colorectal cancer screening depends on timely diagnostic evaluation in patients with abnormal results on fecal immunochemical tests (FITs). Although prior studies suggest low rates of follow-up colonoscopy, there is little information among patients in safety-net health systems and few data characterizing reasons for low follow-up rates. This study aimed to characterize factors contributing to lack of follow-up colonoscopy in a racially diverse and socioeconomically disadvantaged cohort of patients with abnormal results on FIT ("abnormal FIT" for brevity) receiving care in an integrated safety-net health system.
METHODS: We performed a retrospective electronic medical record review of patients aged 50-64 years with abnormal FIT at a population-based safety-net health system between January 2010 and July 2013. Review of electronic medical records focused on patients without follow-up colonoscopy to characterize patient-, provider-, and system-level reasons for lack of diagnostic evaluation. We used logistic regression analysis to identify predictors of follow-up colonoscopy within 12 months of abnormal FIT.
RESULTS: Of 1267 patients with abnormal FIT, 536 (42.3%) failed to undergo follow-up colonoscopy within 1 year. Failure was attributable to patient-level factors in 307 (57%) cases, provider factors in 97 (18%) cases, and system factors in 118 (22%) cases. In multivariate analysis, follow-up colonoscopy was less likely among those aged 61-64 years (odds ratio 0.63, 95% confidence interval 0.46-0.87) compared with 50-55 year olds.
CONCLUSIONS: Nearly half (42%) of patients with abnormal FIT failed to undergo follow-up colonoscopy within 1 year. Lack of diagnostic evaluation is related to a combination of patient-, provider-, and system-level factors, highlighting the need for multilevel interventions to improve follow-up colonoscopy completion rates.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colonoscopy; Colorectal cancer screening; Fecal immunochemical test; Randomized controlled trial; Safety-net health system

Mesh:

Year:  2016        PMID: 27591183      PMCID: PMC5164844          DOI: 10.1016/j.amjmed.2016.07.028

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.

Authors:  K R Yabroff; J F Kerner; J S Mandelblatt
Journal:  Prev Med       Date:  2000-10       Impact factor: 4.018

Review 2.  Challenges and possible solutions to colorectal cancer screening for the underserved.

Authors:  Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

3.  The relative importance of patient-reported barriers to colorectal cancer screening.

Authors:  Resa M Jones; Steven H Woolf; Tina D Cunningham; Robert E Johnson; Alex H Krist; Stephen F Rothemich; Sally W Vernon
Journal:  Am J Prev Med       Date:  2010-03-28       Impact factor: 5.043

4.  How can we boost colorectal and hepatocellular cancer screening among underserved populations?

Authors:  Melissa Goebel; Amit G Singal; Jesse Nodora; Sheila F Castañeda; Elena Martinez; Chyke Doubeni; Adeyinka Laiyemo; Samir Gupta
Journal:  Curr Gastroenterol Rep       Date:  2015-06

5.  Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?

Authors:  Charlotte M Carlson; Katharine A Kirby; Michele A Casadei; Melissa R Partin; Christine E Kistler; Louise C Walter
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Authors:  Elisabeth F Beaber; Jane J Kim; Marilyn M Schapira; Anna N A Tosteson; Ann G Zauber; Ann M Geiger; Aruna Kamineni; Donald L Weaver; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2015-05-07       Impact factor: 13.506

8.  Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

Authors:  Ann C DeBourcy; Scott Lichtenberger; Susanne Felton; Kiel T Butterfield; Dennis J Ahnen; Thomas D Denberg
Journal:  J Gen Intern Med       Date:  2007-12-21       Impact factor: 5.128

9.  The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium.

Authors:  Jasmin A Tiro; Aruna Kamineni; Theodore R Levin; Yingye Zheng; Joanne S Schottinger; Carolyn M Rutter; Douglas A Corley; Celette S Skinner; Jessica Chubak; Chyke A Doubeni; Ethan A Halm; Samir Gupta; Karen J Wernli; Carrie Klabunde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-10       Impact factor: 4.254

10.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

View more
  41 in total

1.  Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Reinier G S Meester; Samir Gupta; Robert E Schoen
Journal:  Gastroenterology       Date:  2019-03-28       Impact factor: 22.682

2.  Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.

Authors:  Katelyn K Jetelina; Joshua S Yudkin; Stacie Miller; Emily Berry; Alicea Lieberman; Samir Gupta; Bijal A Balasubramanian
Journal:  J Gen Intern Med       Date:  2019-06-21       Impact factor: 5.128

3.  Importance of Age-Specific Insurer Perspective on Lifetime Cost Effectiveness of Colorectal Cancer Screening.

Authors:  Audrey H Calderwood
Journal:  Am J Gastroenterol       Date:  2018-10-29       Impact factor: 10.864

4.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

5.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

Authors:  Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

6.  Cancer care coordination: opportunities for healthcare delivery research.

Authors:  Sallie J Weaver; Paul B Jacobsen
Journal:  Transl Behav Med       Date:  2018-05-23       Impact factor: 3.046

7.  Making FIT Count: Maximizing Appropriate Use of the Fecal Immunochemical Test for Colorectal Cancer Screening Programs.

Authors:  Vivy T Cusumano; Folasade P May
Journal:  J Gen Intern Med       Date:  2020-03-03       Impact factor: 5.128

8.  Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.

Authors:  Kathryn E Kemper; Becky L Glaze; Casey L Eastman; Roxane C Waldron; Sonja Hoover; T'Ronda Flagg; Florence K L Tangka; Sujha Subramanian
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

9.  Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.

Authors:  Balambal Bharti; Folasade Fola Popoola May; Jesse Nodora; María Elena Martínez; Karina Moyano; Shauntay L Davis; Christian B Ramers; Felipe Garcia-Bigley; Shawne O'Connell; Kevin Ronan; Melissa Barajas; Sheree Gordon; Giselle Diaz; Evelyn Ceja; Meghan Powers; Elva M Arredondo; Samir Gupta
Journal:  Cancer       Date:  2019-09-03       Impact factor: 6.860

10.  Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think.

Authors:  John S Luque; Kristin Wallace; Bridgette F Blankenship; Lydia G Roos; Franklin G Berger; Nancy R LaPelle; Cathy L Melvin
Journal:  J Community Health       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.